Generic medicine

Cabazitaxel: Brands, Price & Uses in Bangladesh

Cabazitaxel is an antineoplastic (anticancer) taxane medicine used in oncology.

Forms:IV Infusion

About Cabazitaxel

Indications of Cabazitaxel

Cabazitaxel is an antineoplastic (anticancer) taxane medicine used in oncology.

Established / FDA-approved use

  • In combination with oral prednisone (or prednisolone), Cabazitaxel is indicated for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC) who have previously been treated with a docetaxel-containing chemotherapy regimen.

Important notes on use

  • Cabazitaxel is only used after prior docetaxel therapy has failed or disease has progressed; it is not a first-line treatment for prostate cancer.
  • Cabazitaxel must always be given in combination with prednisone/prednisolone as part of the approved regimen, not as monotherapy.
  • There is no approved indication for Cabazitaxel outside metastatic castration-resistant prostate cancer; use in other cancers is investigational/off-label and should only occur within a clinical trial or under specialist oncology direction.
  • Cabazitaxel must be prescribed and administered only by a qualified oncology specialist in a hospital or cancer-care facility equipped to manage severe neutropenia and infusion reactions.

Dosage & Administration of Cabazitaxel

Standard adult dosing (metastatic castration-resistant prostate cancer)

RegimenDoseFrequencyCompanion therapy
Standard20 mg/m² IV infusion over 1 hourEvery 3 weeksOral prednisone/prednisolone 10 mg once daily throughout treatment
Selected patients (per specialist assessment)25 mg/m² IV infusion over 1 hourEvery 3 weeksOral prednisone/prednisolone 10 mg once daily throughout treatment

Treatment should not be initiated if the neutrophil count is at or below the safety threshold (≤1,500 cells/mm³); blood counts must be checked before every cycle and regularly (e.g. weekly during cycle 1).

Mandatory premedication

At least 30 minutes before every infusion of Cabazitaxel, patients should receive premedication with an antihistamine, a corticosteroid (e.g. dexamethasone), and an H2-receptor antagonist, to reduce the risk of hypersensitivity reactions - this is particularly important before the first two infusions.

Hepatic impairment dose adjustment

Hepatic functionRecommended dose
Mild impairment20 mg/m²
Moderate impairment15 mg/m²
Severe impairmentContraindicated - see Contraindications

Dose modification for toxicity

Dose delay and/or reduction (e.g. from 25 mg/m² to 20 mg/m², or from 20 mg/m² to 15 mg/m²) is required for prolonged severe neutropenia, febrile neutropenia, severe (grade ≥3) diarrhoea, or grade 2 or worse peripheral neuropathy, per the treating oncologist's protocol; treatment is discontinued for severe peripheral neuropathy. See Precautions and Warnings for boxed-warning detail on neutropenia.

Concomitant strong CYP3A inhibitors

If a strong CYP3A inhibitor cannot be avoided, a dose reduction of approximately 25% for Cabazitaxel should be considered - see Interactions.

Side Effects of Cabazitaxel

Very common (may affect more than 1 in 10 people)

SystemEffect
BloodNeutropenia, anaemia, leukopenia (often severe and requiring monitoring - see Precautions)
GastrointestinalDiarrhoea, nausea, vomiting, constipation, abdominal pain, decreased appetite
GeneralFatigue, asthenia (weakness), back pain
UrinaryHaematuria (blood in urine)

Common / serious effects requiring prompt medical attention

  • Febrile neutropenia (fever with a low white blood cell count) - a medical emergency, see boxed warning in Precautions.
  • Hypersensitivity reactions - rash, flushing, hypotension, breathing difficulty (bronchospasm) during or shortly after infusion.
  • Peripheral neuropathy - numbness, tingling, or pain in the hands or feet.
  • Severe or persistent diarrhoea leading to dehydration.
  • Renal (kidney) impairment, particularly with dehydration or infection.
  • Cystitis or blood in the urine, especially in patients with prior pelvic radiation.
  • Cough, shortness of breath, or signs of lung inflammation (interstitial lung disease/pneumonitis).

Patients should contact their treating oncology team immediately if fever, signs of infection, severe diarrhoea, breathing difficulty, or unusual bleeding/bruising occur.

Contraindications of Cabazitaxel

  • Known severe hypersensitivity to Cabazitaxel, other taxanes, or to polysorbate 80 (an excipient in the formulation).
  • Neutrophil count at or below 1,500 cells/mm³ (severe neutropenia) at the time treatment is due.
  • Severe hepatic (liver) impairment (bilirubin greater than 3 times the upper limit of normal).

Frequently Asked Questions about Cabazitaxel

What is Cabazitaxel used for?

Cabazitaxel is a chemotherapy medicine used, together with prednisone, to treat men with metastatic castration-resistant prostate cancer whose disease has previously been treated with a docetaxel-containing chemotherapy regimen.

How is Cabazitaxel given?

Cabazitaxel is given only as a slow intravenous infusion (usually over about 1 hour) in a hospital or oncology infusion unit, every 3 weeks, together with daily oral prednisone. It is not a tablet and cannot be taken at home.

What are the most serious risks of Cabazitaxel?

The most serious risk is severe, sometimes life-threatening, neutropenia (a large drop in white blood cells), which increases the risk of serious infection and, rarely, has led to death. Regular blood tests are required before and during treatment, and your oncology team may give you medicine (growth factor injections) to help protect your white blood cell count.

Why do I need other medicines before my Cabazitaxel infusion?

You will be given an antihistamine, a steroid, and an acid-reducing medicine before each Cabazitaxel infusion to reduce the risk of a serious allergic (hypersensitivity) reaction, which is more likely during the first two infusions.

Can Cabazitaxel be used in women or children?

No. Cabazitaxel is approved only for prostate cancer, which occurs in men, and its safety and effectiveness in children have not been established, so it is not used in the pediatric population.

What should I do if I miss a dose or a cycle is delayed?

Cabazitaxel is scheduled and administered entirely by your oncology team based on your blood counts and side effects; do not try to arrange or adjust doses yourself. If a scheduled visit is missed, contact your treating oncology team as soon as possible to reschedule.

Disclaimer

The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.

DoctorBlogArticles